Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.05 - $2.9 $21,210 - $58,580
-20,200 Reduced 39.46%
30,995 $89,000
Q3 2023

Nov 14, 2023

SELL
$1.29 - $2.22 $64,874 - $111,643
-50,290 Reduced 49.55%
51,195 $69,000
Q2 2023

Aug 14, 2023

SELL
$2.07 - $2.92 $108,776 - $153,443
-52,549 Reduced 34.12%
101,485 $218,000
Q1 2023

May 15, 2023

BUY
$2.81 - $6.71 $10,765 - $25,706
3,831 Added 2.55%
154,034 $448,000
Q4 2022

Feb 14, 2023

BUY
$2.74 - $6.87 $134,772 - $337,914
49,187 Added 48.69%
150,203 $1.03 Million
Q3 2022

Nov 14, 2022

BUY
$2.35 - $4.66 $172,743 - $342,547
73,508 Added 267.22%
101,016 $321,000
Q2 2022

Aug 15, 2022

SELL
$2.09 - $3.71 $2,073 - $3,680
-992 Reduced 3.48%
27,508 $88,000
Q1 2022

May 16, 2022

SELL
$2.84 - $4.52 $236,373 - $376,199
-83,230 Reduced 74.49%
28,500 $86,000
Q4 2021

Feb 14, 2022

SELL
$3.87 - $6.59 $828,590 - $1.41 Million
-214,106 Reduced 65.71%
111,730 $498,000
Q3 2021

Nov 15, 2021

BUY
$6.22 - $15.54 $831,837 - $2.08 Million
133,736 Added 69.62%
325,836 $2.14 Million
Q2 2021

Aug 16, 2021

SELL
$10.15 - $17.25 $631,472 - $1.07 Million
-62,214 Reduced 24.46%
192,100 $3.08 Million
Q1 2021

May 17, 2021

BUY
$10.6 - $21.27 $2.7 Million - $5.41 Million
254,314 New
254,314 $3.15 Million
Q3 2020

Nov 16, 2020

SELL
$1.82 - $5.87 $310,490 - $1 Million
-170,599 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$1.41 - $2.61 $49,496 - $91,621
-35,104 Reduced 17.07%
170,599 $329,000
Q1 2020

May 15, 2020

BUY
$1.28 - $4.5 $160,348 - $563,724
125,272 Added 155.75%
205,703 $389,000
Q4 2019

Feb 14, 2020

BUY
$4.03 - $9.22 $324,136 - $741,573
80,431 New
80,431 $361,000
Q2 2019

Aug 14, 2019

SELL
$9.0 - $17.2 $175,617 - $335,623
-19,513 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$13.6 - $19.58 $265,376 - $382,064
19,513 New
19,513 $298,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $80.8M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.